What Secondary Offerings Are and Why They Move Stocks
A secondary equity offering (also called a follow-on offering or FO) occurs when a publicly listed company issues and sells new shares to raise additional capital. Unlike a secondary sale — where existing shareholders sell their own shares to the public — a primary offering creates new shares, increasing the total count outstanding and diluting the ownership percentage of existing shareholders. The immediate mechanical effect is that each existing share now represents a smaller fraction of the company's earnings, book value, and future cash flows.
Stock prices typically decline on secondary offering announcements, for two reasons: (1) the mechanical dilution effect reduces per-share intrinsic value if the proceeds are not immediately deployed to equally high-return uses; and (2) the offering reveals information about the company's capital needs — if the company is issuing equity, it either has an attractive growth opportunity requiring more capital than its cash flow provides, or it does not have access to debt (or debt is too expensive) because lenders do not believe its credit risk is manageable. The market's interpretation of which scenario is occurring determines the magnitude and direction of the price reaction.
Key Takeaways
- Primary vs. secondary offering distinctions matter: A primary offering creates new shares and raises cash for the company. A secondary offering sells existing shareholder shares — no cash goes to the company, but it creates a liquid market for insiders or PE backers exiting. A "mixed" offering combines both. Signal quality differs: primary offerings reveal company capital needs; secondary sales by insiders reveal their personal liquidity preferences.
- Offering discount is typically 3–8%: Follow-on equity offerings are priced at a discount to the prior close to attract buyers who will commit to a large block trade. Larger discounts signal weaker demand for the shares or more urgent capital need. Smaller discounts (or negligible discounts in ATM offerings) reflect strong market demand and company bargaining power.
- Dilution per share is the correct metric, not total dilution %: Issuing 5% more shares reduces each existing share's claim to earnings and assets by approximately 1/1.05 − 1 = −4.76%. The net effect on per-share value depends entirely on the return the company earns on the proceeds relative to its cost of equity capital.
- At-the-market (ATM) offerings are gradual and low-signal: ATM programs allow companies to sell shares directly into the market over time at prevailing prices. They produce less immediate price impact than marketed deals but create ongoing dilution overhang. Companies with established ATM programs sell equity opportunistically at high prices.
- Bought deals eliminate market risk but not dilution: In a bought deal, an investment bank underwrites the entire offering immediately, taking the shares onto its own balance sheet. The bank then resells to investors. The company receives certainty of execution but typically at a larger discount (5–8%) than a marketed deal. Bought deals complete faster (often overnight) and signal urgency.
- Use of proceeds is the primary signal classifier: Growth capex, product development, or strategic acquisitions are positive interpretations; debt refinancing or "general corporate purposes" (a euphemism for covering operating losses) are negative. Dilution for growth is often value-creating over a multi-year horizon; dilution for survival is value-destroying.
- Overhangs persist after offerings: Lockup expiration dates (typically 60–90 days after the offering) are known future selling events. At expiration, employees, insiders, and institutional sellers who participated in the offering may sell freely — creating a predictable supply increase that often depresses the stock in the weeks around lockup expiry.
Core Concepts and Mechanics
1. Offering Mechanics: From S-3 to Closing
Most secondary offerings by existing public companies use a shelf registration (Form S-3), which allows a company to register a large amount of securities in advance and then draw down from that shelf registration when market conditions are favorable. A company with an effective shelf registration can launch an offering on one day and close it the next — this speed advantage is critical for executing in favorable market windows. Companies without an effective shelf (typically smaller or younger public companies) must file a new registration statement that takes weeks or months to become effective, limiting their ability to time offerings.
The typical timeline for a marketed follow-on offering: after market close on day 0, the company files a prospectus supplement and announces the offering size. Investment bank sales desks begin calling institutional investors overnight. By mid-morning on day 1, the deal is priced (determining the offering price, typically at a 3–6% discount to the prior close). Shares are allocated to institutional buyers. Trading in the new shares begins day 1 or 2, and the offering closes (company receives proceeds) day 3. The entire process takes 48–72 hours from announcement to closing.
An accelerated bookbuilt offering (ABO) compresses this further — the company launches after market close, prices and allocates within 2–4 hours, and announces the result the same night. ABOs are used when market windows are short or the company wants to minimize the period of uncertainty. The tradeoff is that the bank has less time to identify demand, potentially requiring a larger discount to attract buyers on a compressed timeline.
2. The Dilution Math: Per-Share Value Impact
Dilution math is straightforward but often misapplied. If a company with 100 million shares outstanding issues 10 million new shares, the new share count is 110 million. Dilution = 10M / 110M = 9.09% of new total outstanding. Each existing share now owns 100/110 = 90.91% of what it owned before — a dilution of 9.09% in proportional ownership.
The per-share impact on intrinsic value depends on the offering price vs. intrinsic value per share. Suppose the stock trades at $50, intrinsic value is $50, and the company issues 10 million new shares at $46 (8% discount). Cash received: 10M × $46 = $460 million. Pro-forma total assets increase by $460 million. If we assume this cash is held as cash (no immediate deployment), the new theoretical value per share is: (original equity value + proceeds) / new share count = ($50 × 100M + $460M) / 110M = $5,460M / 110M = $49.64. The theoretical dilution from this transaction is ($50 − $49.64) / $50 = −0.73% — substantially less than the 9.09% headline dilution figure, because the company is also receiving nearly the stock's intrinsic value in cash (only the 8% discount represents the "give-away" to new investors).
The practical implication: headline dilution percentage overstates the intrinsic value impact when shares are issued near intrinsic value. The damage to existing shareholders is the discount to intrinsic value times the number of new shares issued — not the total new shares issued times the full per-share price. Conversely, when a company issues equity far below intrinsic value (a distressed offering at a 30–40% discount), the dilution to existing holders is severe because the company is effectively giving away value to new investors.
3. At-the-Market (ATM) Programs: Continuous Dilution Machinery
An at-the-market offering program is a standing shelf registration that allows a company to sell new shares directly into the market through a designated broker-dealer during normal trading hours at prevailing market prices, without announcing each sale in advance. The company discloses the existence of the ATM program in an S-3 or prospectus supplement and then reports sales quarterly in its 10-Q filings.
ATM programs are common among growth companies, REITs, and biotech firms that require ongoing equity capital. Their advantages: no announcement gap (the stock doesn't plunge on an offering announcement because each tranche is sold gradually), flexibility to sell at high prices, and no offering discount requirement (shares are sold at market price). Their disadvantages: the program is known to exist, creating an ongoing dilution overhang that can suppress the stock; companies may be tempted to maximize issuance at high valuations rather than deploying capital efficiently; and disclosure of ATM activity (quarterly) comes with a lag, making it harder for investors to track real-time dilution.
For companies with established ATM programs, tracking the quarterly dilution from ATM sales (in the equity footnote of the 10-Q) is a necessary part of understanding the dilution trend. A company that uses its ATM aggressively during a period when its stock is at 52-week highs may be signaling management's view that the stock is fully valued — a mixed signal at best.
4. Reading the Signal: Growth Capital vs. Rescue Offering
The market's initial reaction to a secondary offering is a rapid assessment of "why is this company raising equity now?" The stated "use of proceeds" section of the prospectus is the starting point, but the context around the offering provides the real signal.
Positive offering signals: (a) The company is growing faster than its free cash flow can fund — it needs capital for a new plant, a product launch, or an acquisition, and has a credible plan to generate returns above its cost of equity. (b) The offering is small relative to the company's market cap (less than 5–8%), suggesting a targeted capital need rather than a structural funding crisis. (c) The discount is modest (3–5%), indicating strong institutional demand. (d) Insiders are participating or maintaining their percentage ownership (by buying in the offering or waiving their dilution).
Negative offering signals: (a) The company's stated use is "general corporate purposes" or "working capital" — these phrases often mean the company is burning cash faster than projected and needs equity to continue operating. (b) The offering is large relative to market cap (15–25%+), suggesting urgent need. (c) The discount is large (10%+), reflecting weak institutional demand. (d) Insiders are selling secondary shares in the same offering — they are using the company's capital need as an exit opportunity. (e) The offering occurs shortly after a significant operational setback (missed earnings, pipeline failure, contract loss). The company has lost access to debt markets or finds debt too expensive because its risk profile has deteriorated.
5. Lockup Expirations: The Known Future Overhang
Follow-on offerings include lockup agreements in which existing shareholders — employees, insiders, pre-IPO investors, and sometimes the offering's new investors — agree not to sell their shares for a defined period after the offering. Lockup periods are typically 60–90 days (shorter than the 180-day IPO lockup). The expiration of a lockup creates a predictable future supply event: on or after the lockup expiration date, previously locked-up shareholders may sell freely.
Stocks with large secondary offering lockup expirations often face selling pressure in the 2–4 weeks before and immediately after the expiration date. The pattern is well-documented for IPO lockup expirations and also applies to follow-on offering lockups, though the effect is smaller because most follow-on offering participants are institutional buyers who may not be short-term sellers. The overhang is larger when: (a) the stock has rallied significantly since the offering (locked-up insiders have large unrealized gains and strong selling motivation); (b) a large percentage of shares outstanding are locked up; or (c) the locked-up holders are late-stage private investors whose fund return is contingent on distributing shares to their LPs.
6. Shelf Takedowns and Convertible Notes: Related Dilution Events
Beyond straight equity offerings, companies can raise equity capital through convertible notes — debt instruments that can be converted into shares at a defined strike price. Convertibles are often marketed as "debt" in press releases but create significant equity dilution when they convert. The dilution from a $500 million convertible note at a 35% premium to the current stock price is predictable and quantifiable — it adds to the shares outstanding if and when the stock exceeds the conversion price.
Many growth and tech companies use convertibles as a low-cost capital source (lower cash coupon than straight debt because of the equity optionality), accepting the future dilution when the stock appreciates. Understanding the conversion terms — strike price, conversion ratio, maturity date — allows investors to estimate the future share count under different stock price scenarios. When modeling per-share value for a company with outstanding convertibles, including the diluted share count under the treasury stock method (treating in-the-money options and converts as if exercised, net of shares repurchasable with proceeds) gives a more accurate per-share valuation.
Worked Scenario
Hypothetical example — for education only.
- Starting state: A biotech company has 80 million shares outstanding, a stock price of $35, and a market cap of $2.8 billion. The company has $200 million in cash and burns $60 million per quarter. At this burn rate, it has approximately 3 quarters of runway before needing additional capital.
- Offering announcement (after close): The company announces an offering of 12 million new shares (15% of current count) plus a 1.8 million share over-allotment option (the "greenshoe"), priced at $32 per share — an 8.6% discount to the prior day's close. Gross proceeds: $384 million (before underwriting discount of ~5% = $19.2M; net proceeds = $364.8M). Use of proceeds: advancing three clinical programs through Phase 2 trials.
- Dilution calculation: New shares (assuming greenshoe exercised): 12M + 1.8M = 13.8M. New share count: 80M + 13.8M = 93.8M. Dilution: 13.8M / 93.8M = 14.7%. Theoretical per-share value after offering: ($35 × 80M + $364.8M net proceeds) / 93.8M = ($2,800M + $364.8M) / 93.8M = $3,164.8M / 93.8M = $33.74 per share — a 3.6% dilution to intrinsic value on the assumption the proceeds are held as cash with no immediate value creation.
- Market reaction: The stock opens at $31.50 the next morning — a 10% decline from the prior close, larger than the theoretical dilution. This gap between actual market reaction (−10%) and theoretical dilution (−3.6%) reflects: (a) the market's skepticism about whether the clinical programs will generate the implied return on the raised capital; (b) supply/demand pressure from short sellers shorting the stock against the offering; and (c) uncertainty overhang as investors wait to see who participated and at what allocation.
- Signal interpretation: In this case, the offering is positive-signal: the company has specific clinical programs (not "general corporate purposes"), the discount is moderately wide (8.6%) but not extreme, and the offering fully funds the company through the next two data readouts. A negative signal would have been if a major insider was selling secondary shares in the same offering, or if the stated use was "working capital" rather than program funding.
- Lockup expiration (day 60 after offering): The 60-day lockup expires. Existing shareholders who were locked up can now sell. Because the stock has recovered to $34 (close to pre-offering levels), the overhang effect is modest — no large locked-up seller has a strong motivation to sell at essentially the pre-offering price. If the stock had rallied to $45, the lockup expiration would create much larger selling pressure.
Measurement Framework
| Measurement | What it tells you |
|---|---|
| Offering size as % of shares outstanding | Small (less than 5–8%): targeted capital need, likely positive signal if proceeds are deployed productively. Large (15%+): more urgent need, higher potential dilution impact, requires careful use-of-proceeds analysis. |
| Offering discount to prior close | 3–5%: strong institutional demand, company has leverage. 8–12%: moderate demand or urgency. Above 15%: weak demand or financial distress signaling. Compare to typical sector norms (biotech run higher discounts than large-cap industrials). |
| Theoretical per-share value impact (formula above) | Quantifies the true intrinsic value dilution, adjusting for cash received. Should be smaller in magnitude than the headline dilution % whenever shares are issued near intrinsic value. |
| Use of proceeds specificity | "Growth capex," "product development," "acquisition" = positive interpretation. "General corporate purposes," "working capital," "debt repayment" = negative or neutral interpretation. More specific = better signal quality. |
| Insider participation or secondary shares sold by insiders | Insiders buying in the offering (unusual) signals confidence. Insiders selling secondary shares in the same offering signals desire to exit — particularly negative when coinciding with the company's primary offering. |
| Cash runway pre-offering vs. post-offering | Pre-offering runway below 2–3 quarters signals distress-driven offering. Post-offering runway of 4+ quarters provides operational flexibility. Calculate: (existing cash + net proceeds) / quarterly cash burn. |
| Lockup expiration date | Mark on the calendar 60–90 days post-offering. Track shares locked up relative to total float. Large locked-up share count + significant stock appreciation since offering = elevated selling pressure risk at expiration. |
Common Failure Modes
Confusing Dilution % with Intrinsic Value Impact
A 15% offering at a price near intrinsic value dilutes ownership by 15% but dilutes intrinsic value per share by a much smaller amount — because the company received 92% of fair value in cash (assuming 8% discount), which offsets most of the ownership dilution. Investors who sell reflexively on any large offering announcement without computing the actual per-share value impact may exit positions at a temporary discount to intrinsic value, selling into the very supply-created weakness that will dissipate once the offering settles.
The corrective is a fast calculation: (existing market cap + net proceeds) / (new share count). If the result is close to the pre-offering stock price, the real dilution is modest. If the result is well below the pre-offering price — because the offering is very large or priced at a large discount — the dilution is material and the reflexive sell decision may be correct.
Ignoring Serial Diluters
Some companies have a history of repeatedly returning to the equity market to fund ongoing operations — conducting multiple follow-on offerings over a multi-year period. Each individual offering may appear manageable, but the cumulative dilution over 3–5 years can be severe. A company that had 50 million shares outstanding in 2020 and now has 180 million shares has diluted original shareholders by 72%. Tracking shares outstanding over time (from the cover page of each 10-K) is the simplest check on cumulative dilution history.
Serial diluters are often growth-stage companies with compelling stories but insufficient cash flow to fund their own growth. They are not inherently bad investments — if the capital is being deployed to genuinely high-return opportunities, cumulative dilution can be offset by fundamental value creation. But the rate of dilution must be compared to the rate of intrinsic value creation; only the net is what shareholders actually benefit from.
Buying Immediately Post-Announcement Without Checking Insider Selling
Mixed offerings — where the company issues primary shares and existing shareholders simultaneously sell secondary shares — are common. On the surface, the press release describes a capital raise for growth. In the detail of the prospectus supplement, insiders are selling millions of their personal shares at the same time. These mixed offerings often produce a larger initial price decline than pure primary offerings because they combine true dilution (new shares) with information content (insiders are selling personal stakes while the company raises external capital). Reading the full preliminary prospectus (available on SEC EDGAR within hours of announcement) before trading any post-announcement reaction is essential.
Not Accounting for Lockup Expirations in Return Calculations
A position established at an attractive price during post-announcement weakness may face a predictable headwind at the lockup expiration 60–90 days later, particularly if the stock has rallied. Ignoring this known future event in return calculations overstates the risk-adjusted expected return. Position management — reducing size ahead of lockup expirations when the stock has rallied significantly — is a common institutional practice around post-offering positions.
Frequently Asked Questions
What is the difference between a primary and a secondary offering?
A primary offering issues new shares created by the company — the company receives the cash proceeds and shares outstanding increase. A secondary offering is a sale of existing shares by current shareholders (insiders, PE sponsors, pre-IPO investors) — the selling shareholders receive the cash, not the company, and shares outstanding do not change. A "secondary" offering in the informal sense often refers to any follow-on offering after an IPO, including mixtures of both primary and secondary components. Reading the prospectus's "selling shareholders" section clarifies exactly who receives the proceeds from each component.
What is the greenshoe option and why does it matter?
The greenshoe (or overallotment option) is an option granted by the company to the underwriting bank to purchase additional shares — typically up to 15% of the offering size — at the offering price, within 30 days after the offering. The bank uses the greenshoe to stabilize the stock price after the offering: if the stock trades below the offering price, the bank buys shares in the open market (providing price support) rather than exercising the greenshoe, then closes its short position with the purchased shares. If the stock trades at or above the offering price, the bank exercises the greenshoe to acquire additional shares from the company at the offering price, selling them to meet investor demand. Greenshoe exercises are mildly dilutive (up to 15% additional shares issued) and signal that demand was strong enough that the bank needed more shares.
What is a "bought deal" and how does it differ from a marketed offering?
In a bought deal, the investment bank immediately underwrites the entire offering at a fixed price, taking the shares onto its own balance sheet and accepting full market risk. The company receives certainty that the entire offering will close regardless of market conditions. The bank then resells to investors over the following hours or days. Because the bank bears the risk, it demands a larger discount (often 5–8%) than a marketed deal. Bought deals complete overnight, before any market reaction can develop, which is why companies choose them when they want speed or fear market deterioration. Marketed deals involve building a book of investor demand before pricing, typically over 24–48 hours, allowing the bank to price more tightly but accepting more uncertainty during the bookbuilding period.
How do at-the-market (ATM) programs work in practice?
An ATM program is established through a prospectus supplement filed with the SEC designating a bank as the company's ATM agent. The agent then sells shares on the company's behalf at prevailing market prices during regular trading hours, typically in small blocks that minimize market impact. The company instructs the agent on the maximum amount to sell on any given day and can pause or restart the program. Sales are reported quarterly in the 10-Q with total shares sold, average price, and net proceeds. ATM programs are most valuable when the stock is at or near all-time highs — companies with disciplined ATM programs build capital by selling at high prices over time rather than concentrating sales in large, discount-requiring offerings.
What does "use of proceeds" tell me about the offering's signal quality?
Use of proceeds is the most informative signal in a secondary offering announcement, but it must be read critically. "Capital expenditures for expansion" or "funding of the [specific project]" describe specific, verifiable plans with potential return on investment. "General corporate purposes" is intentionally vague and often means covering operating losses or maintaining liquidity — the company is raising equity because it must, not because it has identified high-return opportunities. "Repayment of borrowings" indicates the company needs equity to reduce leverage — potentially positive if it reduces financial risk, or negative if it signals the company took on too much debt in the first place. The quality of the stated use, combined with the company's track record of capital deployment, determines whether the offering is likely to create or destroy per-share value over time.
How do I model the post-offering price reaction?
A simple model: theoretical post-offering share price = (pre-offering market cap + net proceeds) / post-offering share count. This estimates where the stock should trade if the market assigns full credit for the cash raised. Actual post-offering price typically trades below this level immediately after announcement, due to: supply/demand pressure from short sellers hedging the offering, overhang from potential additional selling, and uncertainty about whether the capital will be deployed effectively. The gap between theoretical fair value and actual post-announcement price can create an entry opportunity for investors who believe the offering is fundamentally sound. Our dilution impact calculator automates this calculation.
What is a "shelf registration" and why does it matter for offering timing?
A shelf registration (Form S-3) allows a company to register a large amount of securities with the SEC in advance, then draw down from that registration in smaller tranches over a period of up to three years. Once the shelf is effective (typically within 20–30 days of filing), the company can launch an offering with no additional SEC review required — dramatically compressing the announcement-to-close timeline. Companies that regularly access equity markets maintain active shelf registrations specifically for this flexibility. Smaller or newer public companies may not qualify for shelf registration (they need a minimum market float and at least 12 months of SEC reporting history), which means they must file a new registration statement each time and cannot execute an overnight offering.
How do convertible notes differ from direct equity offerings in their dilution impact?
Convertible notes are debt instruments with an option to convert into equity at a predetermined price (the "conversion price"), typically set at a 25–40% premium to the stock price at issuance. They pay a lower cash interest rate than straight debt because the conversion feature has option value. Dilution occurs if and when the stock exceeds the conversion price and note holders convert — until then, they are counted as debt, not equity. The diluted share count under the treasury stock method adds shares from in-the-money converts to the base share count. Convertibles can be advantageous for companies that believe their stock will rise (they are selling equity optionality at high implied prices) but create known future dilution that must be modeled for per-share valuation under different stock price scenarios.
Sources and Further Verification
Disclaimer
This content is for educational and informational purposes only and does not constitute personalized investment, financial, tax, or legal advice. Secondary offerings involve rapid price movements and significant uncertainty about use of proceeds and capital deployment effectiveness. Dilution calculations are illustrative and depend on assumptions about offering price and share count. Consult a qualified financial professional before acting on this information.